Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
Schedule a COVID vaccine appointment:
call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Not accepting new patients
Perelman Center for Advanced Medicine
West Pavilion, 1st Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown below from a 3rd party vendor, Press Ganey and as of 7/01/21, our internal platform, PMX Feedback. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Kim RY, Li Y, Marmarelis ME, Vachani A.: Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesothelioma Lung Cancer 159 : 107-110,2021.
Vachani A, Maldonado F, Laxmanan B, Kalsekar I, Murgu S.: The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy Chest : Online ahead of print,2021.
Burnett-Hartman AN, Carroll NM, Honda SA, Joyce C, Mitra N, Neslund-Dudas C, Olaiya O, Rendle KA, Schnall MD, Vachani A, Ritzwoller DP.: Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: the PROSPR Consortium Ann Am Thorac Soc : Online ahead of print,2021.
Kim RY, Mitra N, Bagley SJ, Marmarelis ME, Haas AR, Rendle KA, Vachani A.: Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma JTO Clinical and Research Reports 2 (6): 100188,2021.
Gould MK, Altman DE, Creekmur B, Qi L, de Bie E, Golden S, Kaplan CP, Kelly K, Miglioretti DL, Mularski RA, Musigdilok VV, Smith-Bindman R, Steltz JP, Wiener RS, Aberle DR, Dyer DS, Vachani A.: Guidelines for the Evaluation of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Awareness, Agreement, and Adherence From the Watch the Spot Trial J Am Coll Radiol 18 (4): 545-553,2021.
Schapira MM, Rodriguez KL, Chhatre S, Fraenkel L, Bastian LA, Kravetz JD, Asan O, Akers S, Vachani A, Prigge JM, Meline J, Ibarra JV, Corn B, Kaminstein D.: When Is a Harm a Harm? Discordance between Patient and Medical Experts' Evaluation of Lung Cancer Screening Attributes Med Decis Making 41 : 317-328,2021.
Tanner NT, Springmeyer SC, Porter A, Jett JR, Mazzone P, Vachani A, Silvestri GA.: Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial Chest 159 : 1283-1287,2021.
Corley DA, Sedki M, Ritzwoller DP, Greenlee RT, Neslund-Dudas C, Rendle KA, Honda SA, Schottinger JE, Udaltsova N, Vachani A, Kobrin S, Li CI, Haas JS.: Cancer Screening during COVID-19: A Perspective from NCI's PROSPR consortium Gastroenterology 160 (4): 999-1002,2021.
Chhatre S, Vachani A, Allison RR, Jayadevappa R.: Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer Cancers (Basel) 13 : 803,2021.
Silvestri GA, Bevill B, Chen A, Pastis NJ, Rivera MP, Tanner NT, Yarmus L, Vachani A.: Response Chest 159 (1): 438-439,2021.
Pulmonary, Allergy, and Critical Care DivisionUniversity of Pennsylvania School of MedicineSuite 216, Stemmler Hall3450 Hamilton Walk
Patient appointments: 800-789-7366